Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Gedea Biotech initiates EpHect Clinical Trial for Antibiotic-free Treatment of Women with Vulvo Vaginal Candidiasis

· Up to 75% of all women are affected by vaginal infection in their lifes · Self-diagnoses leads often to unnecessary and inappropriate treatment use · This study aims to confirm the safety and efficacy of pHyph in VVC Lund, Sweden, May 2, 2023. Gedea Biotech today announces that the treatment of the first patients with its lead product, pHyph, a vaginal tablet for topical treatment, has begun. The open-labelled study is designed to confirm the safety and efficacy of pHyph in treating adult women with confirmed Vulvo Vaginal Candidiasis (VVC) and in restoring a beneficial vaginal

TF Bank AB (publ) gives notice of early redemption of perpetual additional Tier 1 bonds with ISIN SE0011311240

TF Bank AB (publ) (“TF Bank” or the “Bank”) announces that the Bank will carry out an early redemption of all outstanding perpetual additional Tier 1 bonds issued on 7 June 2018 with ISIN SE0011311240 and with a total outstanding nominal amount of SEK 100,000,000 (the “Bonds”) in accordance with the terms and conditions of the Bonds (the “Terms and Conditions”). TF Bank has today, 2 May 2023, sent an irrevocable notice of early redemption to all directly registered owners (Sw. direktregistrerad ägare) and registered authorised nominees (Sw. förvaltare) in the debt register for each Bond

Publication of Anora’s Interim Report for January–March 2023 on 11 May 2023 and invitation to results presentation

Anora Group Plc  Press release  2 May 2023 at 13:45 EEST Publication of Anora’s Interim Report for January–March 2023 on 11 May 2023 and invitation to results presentation Anora will publish its Interim Report for January–March 2023 on Thursday 11 May at around 8:30 am EEST. CEO Pekka Tennilä and CFO Sigmund Toth will present the report on the same day at 11:00 am EEST. The presentation will be held as a Microsoft Teams Meeting and we recommend to join the event through the online option: Join the meeting here 

New Business Update - Ayima Group Limited

Following a difficult beginning to the year where a lot of new business was delayed due to uncertainty about economic conditions, Ayima Group is pleased to announce that the new contracts are now getting signed. Today Ayima signed a contract to provide SEO services to one of the worlds leading brokerage and trading platforms, based in Cyprus and the United Kingdom. The contract is worth approximately 7.5 MSEK for the remainder of the 2023 financial year and will auto-renew annually. In addition, several smaller contracts to the value of 4.2 MSEK annually were signed in recent weeks,

DNV Extends the Offer Period for the Voluntary Recommended Public Cash Tender Offer for all Shares and Stock Options in Nixu

Nixu Corporation, Stock Exchange Release, May 2, 2023, 1:00 p.m. EESTNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THIS TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. The global quality assurance and risk management provider DNV AS (“DNV” or the “Offeror”) has on February 28, 2023, commenced a voluntary recommended public cash tender offer for all the issued and outstanding shares (the “Shares” or, individually, a “Share”)

Endomines Finland Plc’s Annual Report 2022 is published – correction

Correction regarding the ESEF financial statements XHTML file which is unaudited. Endomines Finland Plc – Stock Exchange Release, 2.5.2023, at 13.00 EET Endomines Finland Plc is correcting the Stock Exchange Release published on 28.4.2023, containing incorrect information regarding the ESEF financial statements XHTML file which is unaudited. Below is the corrected release. Endomines Finland Plc's Annual Report 2022 has been published. The Annual Report includes the Report of the Board of Directors, the Financial Statements for 2022, the Corporate Governance Statement, the

HappyHour Leads Seed Extension Round in Betty Gaming

HappyHour.io, an investor in the gaming industry, has announced its investment in Betty.ca, an iCasino live and licensed in Ontario, Canada with plans to expand further into North America.With its expertise in identifying and supporting successful iCasino businesses, HappyHour.io  has chosen to invest in Betty.ca due to the company's unique positioning, proprietary platform and experienced management team. HappyHour believes that Betty is well-placed to challenge the landscape of online casinos made for the sports betting market by creating a ‘safe, social and

Brain+ A/S publishes supplement to prospectus

COMPANY ANNOUNCEMENT Copenhagen, Denmark, May 2, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Brain+ A/S (“Brain+” or the “Company”) has prepared a supplement (the “Supplement”) to the EU growth prospectus (the “

Lindab acquires Firmac, leader in rectangular ventilation duct machinery

Lindab acquires the British company Firmac Ltd, which is the European leader in machines for manufacturing of rectangular ventilation ducts. Through its Spiro business, Lindab is the market leader in machines for manufacturing of circular ventilation ducts.Firmac was founded in 1985 to automate the production of rectangular ventilation ducts. The company is today the market leader in Europe, and exports its high-quality machines to around 50 countries. Sales are largely project-based. "We are very pleased to welcome Firmac to Lindab. It is an excellent complement to Lindab's current

Mukesh Ambani Net Worth – How Asia's Wealthiest Mogul Built His Fortune

Tuesday, May 2, 2023 – Mukesh Ambani, the Indian business magnate and chairman of Reliance Industries, is known for his immense wealth and influence. Business 2 Community has conducted an in-depth analysis of Ambani's financial empire, revealing a net worth of $85.6 billion, making him the 13th wealthiest person on the Forbes Real Time Billionaires List and the richest person in Asia. Mukesh Ambani's Net Worth Relies on Reliance Industries Mukesh Ambani's wealth is primarily derived from his role as chairman and principal shareholder of Reliance Industries, a conglomerate

FDA approves the manufacture of new microbiome-based therapeutic VOWST™ at Recipharm site

Recipharm, a global contract development and manufacturing organization (CDMO), has announced today that its subsidiary, GenIbet Biopharmaceuticals, has been approved by the US Food and Drug Administration (FDA) as a manufacturing site of VOWST, a breakthrough orally administered fecal microbiota product for the prevention of Clostridioides difficile recurrent infection (CDI) in adults following antibacterial treatment for recurrent CDI. Recipharm will manufacture VOWST at its GenIbet site in Oeiras, Portugal on behalf of Seres Therapeutics. In the US, CDI has been classified as one

Klimator contracts one of the largest municipalities in Denmark for smart decision-making solutions for winter road maintenance

Klimator has signed a contract with one of the largest municipalities in Denmark for a full suite of road weather stations and monitoring software for making call-out decisions on road and bicycle lanes. The total order value for the first year is approx. 600 KSEK.The deal is the first one for this size of municipality and establishes Klimator as a supplier across all sizes and types of organisations.   “We are happy to expand our solutions to more and more customers, also seeing larger organisations joining the list. There is a need to focus on cost reductions, but also the

Semcon’s sustainability report 2022

Semcon's sustainability report for 2022 is now published on the company's website.During 2022, Semcon continued to grow its operations with high profitability. The sustainability offering was further strengthened, among other things through the acquisition of the sustainability consulting company Goodpoint. “Many of our customer projects support the transition to a sustainable society. But change needs to be faster. At Semcon, we work decisively with our internal sustainability agenda, but our biggest contribution is through our customer projects. With Semcon’s unique offering, we see

Sitowise Group Plc issues 37,330 own shares in a directed issue relating to acquisition of Infrasuunnittelu Oy

Sitowise Group Plc                        Changes in company's own shares                          2 May 2023 at 12.30 pm EEST The Board of Directors of Sitowise Group Plc (“Sitowise”) has decided on 2 May 2023, by virtue of the authorization granted by the annual general meeting on 25 April 2023, to issue 37,330 own shares (the "Share") held by Sitowise in a directed share issue. The number of Shares to be subscribed for in the share issue (the “Share Issue”) corresponds to approximately 0.10 per cent of shares in Sitowise. The Share Issue relates to an acquisition of all shares in

Resqunit AB - Annual Report 2022

Correction:[This correction is published because the MAR label should not have been included in the previous message]Resqunit AB (publ) ("Resqunit") May 2nd, 2023, at 11.00 CET.2022 compared to 2021 Group revenue have been limited in both yearsOperating profit amounted to -9 324 973 SEK (-11 607 054 SEK)Earnings per share -0,86 SEK (-1,10 SEK) Key figures (SEK) 2022 Group 2021 Group Proforma Unaudited UnauditedNet sales 340 322 66 918Operating profit

Director/PDMR Shareholding

2 May 2023 10:00 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announces that Michel Demaré, Non-Executive Chair of the Board, purchased 2,000 of the Company's ordinary shares of $0.25 each (Ordinary Shares) on 28 April 2023. Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (since it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018). 1 Details of the person discharging managerial responsibilities / person

Alma Finanssipalvelut Oy now licensed to carry out payment intermediation

Alma Media Corporation         Press Release        2 May 2023ALMA FINANSSIPALVELUT OY NOW LICENSED TO CARRY OUT PAYMENT INTERMEDIATION  Alma Media's Alma Finanssipalvelut Oy has been granted a licence to carry out payment intermediation in accordance with the Payment Institutions Act, which can be used, for example, in vehicle trade between consumers. The licence has been granted by the Financial Supervisory Authority. Until now, in Alma Media services, payment intermediation has been provided by partners.   “Payment intermediation will support Alma Media's marketplace business,

Quickbit announces change to Group Management

Today, Quickbit announces that Sneha Patel, Head of Finance, is leaving Quickbit to take on new challenges. At the same time, Daniel Boettge has been appointed as new interim CFO. As of today, May 2, 2023, Daniel replaces Sneha in the Group Management Team.Daniel has a degree in business and law from Stockholm University. He has a lot of experience in finance, accounting and law. Daniel has 15+ years of experience in accounting, organizational development, tax and corporate law. “I want to thank Sneha for her work, professionalism and commitment here at Quickbit. At the same time, I

SAS OPENS NEW ROUTE TO BANGKOK

SAS is continuing to strengthen its offer and to accommodate an increased demand for leisure travel, SAS will now open a new route to Bangkok, Thailand. Following this route expansion travelers will be able to fly direct to Bangkok three times weekly with convenient overnight flights in both directions using the Airbus A350 aircraft.First departure is planned from Copenhagen on the 30[th] of October 2023. “Thailand and the Scandinavian countries have a long history of friendship and cooperation and returning with a direct route after nine years is a true pleasure. The Bangkok route will

Saab’s Giraffe 1X wins UK Ministry of Defence orders

Saab has signed two contracts for eleven Giraffe 1X radars including support with the UK’s Ministry of Defence. The total order value is approximately SEK 264 million and deliveries have already started.The acquisition of Giraffe 1X is largely for operational environments, whilst a single unit has been procured by the Royal Navy and will be mounted and tested on the XV Patrick Blackett. This ship is operated by NavyX to test, trial and experiment with new technologies and concepts. Giraffe 1X is a lightweight, multi-mission, 3D surveillance radar for simultaneous air- and surface

(Reminder) Invitation to Kongsberg Automotive's Q1 2023 Earnings Presentation

Zurich, May 2, 2023: Kongsberg Automotive (KA) will release its Q1 results on Tuesday, May 09, 2023 at approximately 07:00 CET. President & CEO Joerg Buchheim and CFO Frank Heffter will present the results during a webcast at 08:00 CET and will host a Q&A session after the presentation. The event is open to the public and will be webcasted live. The following link https://channel.royalcast.com/landingpage/hegnarmedia/20230509_7/ 

BioStock: Xintela initiates last dose level in knee osteoarthritis study

Xintela recently announced that they have initiated the third and last dose level in the phase I/IIa study with the stem cell product XSTEM in patients with knee osteoarthritis. The company’s goal is to present safety data from all dose levels and early efficacy results in 2023. BioStock contacted Camilla Wennersten, Director Clinical Development at Xintela, to find out more about the study.Read the full article at biostock.se: https://www.biostock.se/en/2023/05/xintela-initiates-last-dose-level-in-knee-osteoarthritis-study/ This is a press release from BioStock - Connecting

Herantis Pharma to participate in Bio€quity Europe 2023 in Dublin May 2023

Herantis Pharma Plc, Press Release, 2 May 2023 at 11:45 A.M. EEST Herantis Pharma Plc (“Herantis”), a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease, today announced that Herantis Pharma has been selected as presenting company with live presentation during the 23rd Bio€quity Europe Conference, in May 14-16, 2023 in Dublin. CEO, Antti Vuolanto will give a company presentation: May 16[th] at 11:39 AM EEST / 10:39 AM CET / 09:39 AM IST Location: Liffey Meeting Room 3, Convention Centre Dublin If you want 1x1 meetings with

There are no items matching the current filter
There are no more items matching the current filter
Back to top